Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 1
1992 1
1993 1
1994 1
1996 2
1998 2
2002 1
2003 1
2004 4
2005 4
2006 2
2007 3
2008 6
2009 3
2010 4
2011 3
2012 2
2014 3
2015 8
2016 6
2017 15
2018 10
2019 6
2020 8
2021 15
2022 9
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
When worlds collide: Th17 and Treg cells in cancer and autoimmunity.
Knochelmann HM, Dwyer CJ, Bailey SR, Amaya SM, Elston DM, Mazza-McCrann JM, Paulos CM. Knochelmann HM, et al. Among authors: paulos cm. Cell Mol Immunol. 2018 May;15(5):458-469. doi: 10.1038/s41423-018-0004-4. Epub 2018 Mar 21. Cell Mol Immunol. 2018. PMID: 29563615 Free PMC article. Review.
A human memory T cell subset with stem cell-like properties.
Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP. Gattinoni L, et al. Among authors: paulos cm. Nat Med. 2011 Sep 18;17(10):1290-7. doi: 10.1038/nm.2446. Nat Med. 2011. PMID: 21926977 Free PMC article.
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.
Liu S, Knochelmann HM, Lomeli SH, Hong A, Richardson M, Yang Z, Lim RJ, Wang Y, Dumitras C, Krysan K, Timmers C, Romeo MJ, Krieg C, O'Quinn EC, Horton JD, Dubinett SM, Paulos CM, Neskey DM, Lo RS. Liu S, et al. Among authors: paulos cm. Cell Rep Med. 2021 Oct 19;2(10):100411. doi: 10.1016/j.xcrm.2021.100411. eCollection 2021 Oct 19. Cell Rep Med. 2021. PMID: 34755131 Free PMC article. Clinical Trial.
IL-2 and Beyond in Cancer Immunotherapy.
Wrangle JM, Patterson A, Johnson CB, Neitzke DJ, Mehrotra S, Denlinger CE, Paulos CM, Li Z, Cole DJ, Rubinstein MP. Wrangle JM, et al. Among authors: paulos cm. J Interferon Cytokine Res. 2018 Feb;38(2):45-68. doi: 10.1089/jir.2017.0101. J Interferon Cytokine Res. 2018. PMID: 29443657 Free PMC article. Review.
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
Qian DC, Kleber T, Brammer B, Xu KM, Switchenko JM, Janopaul-Naylor JR, Zhong J, Yushak ML, Harvey RD, Paulos CM, Lawson DH, Khan MK, Kudchadkar RR, Buchwald ZS. Qian DC, et al. Among authors: paulos cm. Lancet Oncol. 2021 Dec;22(12):1777-1786. doi: 10.1016/S1470-2045(21)00546-5. Epub 2021 Nov 12. Lancet Oncol. 2021. PMID: 34780711 Clinical Trial.
Novel immunotherapies for hematologic malignancies.
Nelson MH, Paulos CM. Nelson MH, et al. Among authors: paulos cm. Immunol Rev. 2015 Jan;263(1):90-105. doi: 10.1111/imr.12245. Immunol Rev. 2015. PMID: 25510273 Free PMC article. Review.
Harnessing the Microbiome to Enhance Cancer Immunotherapy.
Nelson MH, Diven MA, Huff LW, Paulos CM. Nelson MH, et al. Among authors: paulos cm. J Immunol Res. 2015;2015:368736. doi: 10.1155/2015/368736. Epub 2015 May 25. J Immunol Res. 2015. PMID: 26101781 Free PMC article. Review.
135 results